Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Acadia Healthcare Company Inc (NASDAQ: ACHC) was $23.72 for the day, up 0.30% from the previous closing price of $23.65. In other words, the price has increased by $0.30 from its previous closing price. On the day, 2.02 million shares were traded. ACHC stock price reached its highest trading level at $24.42 during the session, while it also had its lowest trading level at $23.535.
Ratios:
Our analysis of ACHC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On February 28, 2025, Barclays Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $43 to $35. KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on January 07, 2025, while the target price for the stock was maintained at $70.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 2190461184 and an Enterprise Value of 4613746176. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.63, and their Forward P/E ratio for the next fiscal year is 8.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at 1.429 whereas that against EBITDA is 7.157.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.89, which has changed by -0.6892034 over the last 52 weeks, in comparison to a change of 0.18469036 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $79.82, while it has fallen to a 52-week low of $17.12. The 50-Day Moving Average of the stock is 7.13%, while the 200-Day Moving Average is calculated to be -21.23%.
Shares Statistics:
ACHC traded an average of 2.18M shares per day over the past three months and 2343760 shares per day over the past ten days. A total of 92.35M shares are outstanding, with a floating share count of 90.68M. Insiders hold about 1.80% of the company’s shares, while institutions hold 115.72% stake in the company. Shares short for ACHC as of 1755216000 were 10777180 with a Short Ratio of 4.94, compared to 1752537600 on 10595146. Therefore, it implies a Short% of Shares Outstanding of 10777180 and a Short% of Float of 13.56.
Earnings Estimates
The current market rating for Acadia Healthcare Company Inc (ACHC) reflects the collective analysis of 13.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.62, with high estimates of $0.79 and low estimates of $0.53.
Analysts are recommending an EPS of between $2.58 and $2.4 for the fiscal current year, implying an average EPS of $2.51. EPS for the following year is $2.76, with 14.0 analysts recommending between $3.13 and $2.35.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 13 analysts. It ranges from a high estimate of $878.2M to a low estimate of $816.76M. As of the current estimate, Acadia Healthcare Company Inc’s year-ago sales were $815.63MFor the next quarter, 13 analysts are estimating revenue of $835.71M. There is a high estimate of $865.67M for the next quarter, whereas the lowest estimate is $821M.
A total of 13 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.35B, while the lowest revenue estimate was $3.3B, resulting in an average revenue estimate of $3.32B. In the same quarter a year ago, actual revenue was $3.15BBased on 13 analysts’ estimates, the company’s revenue will be $3.57B in the next fiscal year. The high estimate is $3.64B and the low estimate is $3.48B.
